Table 2.
Latent Time (min) | Peak Time (min) | Peak Value (nM) | ETP (nM·min) | |
---|---|---|---|---|
WT | 11.9 ± 0.2 (1.00) | 18.6 ± 0.1 (1.00) | 108.9 ± 9.1 (1.00) | 957.9 ± 41.1 (1.00) |
G1750C/R2116C | 11.5 ± 1.2 (0.97) | 20.6 ± 1.0 (1.11) | 45.9 ± 4.5 (0.42) | 514.2 ± 19.7 (0.54) |
A1866C/S2119C | 13.2 ± 3.5 (1.11) | 25.1 ± 2.7 (1.35) | 33.4 ± 1.5 (0.31) | 408.8 ± 36.5 (0.43) |
R2116A | 10.4 ± 0.2 (0.87) | 18.2 ± 0.1 (0.98) | 76.5 ± 8.6 (0.70) | 744.1 ± 91.3 (0.78) |
R2116V | 12.6 ± 0.2 (1.06) | 18.6 ± 0.1 (1.00) | 69.4 ± 3.5 (0.64) | 595.4 ± 4.4 (0.62) |
S2029C/P2292C | 7.8 ± 0.7 (0.66) | 15.1 ± 0.3 (0.81) | 139.6 ±12.8 (1.28) | 1076.0 ± 24.0 (1.12) |
Thrombin generation assays in the presence of 0.25 nM factor VIII proteins, 0.5 pM rTF, and 4 μM PSPCPE vesicles were performed and parameter values were calculated as described in Methods. Data represents the average values ± SD of triplicate samples. Values in parentheses are relative to the WT value. The single letter code is used to designate amino acid residues, G (Gly), R (Arg), A (Ala), S (Ser), C (Cys), V (Val), and P (Pro).